NEW YORK, Dec 19 - Amersham Pharmacia Biotech said Tuesday that it had agreed to exclusively license a technology from Procter & Gamble that would increase the percentage of proteins and peptides that can be identified using APB’s Ettan MALDI-ToF mass spectrometry analysis system.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.